MetaCap

Actinium Pharmaceuticals (Delaware) (ATNM) News

NYSE: ATNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.05-0.02 (-1.87%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ATNM news summary

We found 4 recent headlines mentioning Actinium Pharmaceuticals (Delaware) (ATNM): 0 in the past week and 1 in the past 30 days, most often from PR Newswire, Nasdaq. For price context, ATNM is down 1.87% at $1.05. The most recent story, "Actinium Pharmaceuticals Announces Inducement Grant to New Employee", was published by PR Newswire on Oct 30, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Actinium Pharmaceuticals (Delaware) headlines

Compare ATNM